Oyler was a Founder and the President of Telephia, Inc. Oyler served as Chief Executive Officer of Galenea Corp., a biopharmaceutical company dedicated to the discovery of novel therapies for central nervous system diseases, which initially were developed at Massachusetts Institute of Technology. Oyler served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing company, which was acquired by Pharmaceutical Product Development Inc. Oyler is our Co-Founder and Chairman, and has served as our Chief Executive Officer and a member of our Board of Directors since 2010.
0 kommentar(er)
